In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Sihuan Pharmaceutical grosses HK$5.75bn via its IPO
10 May 2011
Sihuan Pharmaceutical Holdings Group Ltd., China's largest cardio-cerebral vascular drugs producer, has grossed HK$5.75bn ($738mm) through the initial public offering of 1.25bn shares at HK$4.60 each on the Hong Kong Stock Exchange. The shares sold at the top of the range, which began at HK3.88, and the financing was more than 100 times oversubscribed.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?